Lyntriaxone 1g Injection
Product Description
Lyntriaxone 1g Injection is a sterile, broad-spectrum antibiotic containing ceftriaxone sodium, a third-generation cephalosporin used to treat a wide range of serious bacterial infections. It is formulated for intravenous (IV) or intramuscular (IM) administration and is commonly used in hospitals and clinical settings.
Ceftriaxone works by inhibiting bacterial cell wall synthesis, making it effective against both Gram-positive and Gram-negative organisms. It is often used for systemic infections where oral antibiotics are not sufficient or appropriate.
Key Features
- Contains 1g of ceftriaxone sodium per vial
- Effective against a broad range of bacteria
- Suitable for IV or IM injection
- Commonly used in hospital settings for acute infections
- Supplied as a powder for reconstitution before administration
Indications
- Respiratory tract infections (e.g. pneumonia, bronchitis)
- Urinary tract infections (UTIs)
- Skin and soft tissue infections
- Intra-abdominal infections
- Meningitis and septicemia
- Gonorrhea and pelvic inflammatory disease
- Surgical prophylaxis in high-risk procedures
Directions for Use
- For reconstitution and administration by qualified healthcare professionals only.
- Dilute with appropriate sterile diluent as directed in the product insert.
- Dosage depends on infection type, severity, and patient’s age or weight.
- Administered via deep IM injection or slow IV infusion over recommended time.
Precautions
- Contraindicated in patients with known allergy to cephalosporins.
- Caution in patients with penicillin allergies due to possible cross-reactivity.
- Monitor renal and liver function during prolonged therapy.
- Not recommended for neonates with hyperbilirubinemia or calcium-containing IV solutions.
- Store in a cool, dry place; protect from light and moisture.
Important Information
Lyntriaxone 1g Injection is a prescription-only antibiotic intended for use under medical supervision in hospital or clinical settings. Proper diagnosis, dosing, and follow-up are critical to prevent resistance and ensure successful treatment outcomes.